Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PeptiDream Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12
Private Equity 13
Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 13
Partnerships 14
Bayer and PeptiDream Enter into Partnership 14
PeptiDream and Kleo Pharma Enter into Co-Development Agreement 15
Heptares Therapeutics and PeptiDream Enter into Agreement 16
Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 17
PeptiDream Enters into Agreement with Janssen Pharma 18
PeptiDream Enters into Research Agreement with BIND Therapeutics 19
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 20
PeptiDream Enters into Agreement with Genentech 21
Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 22
Teijin Pharma Enters into Discovery Agreement with PeptiDream 23
PeptiDream Enters into Discovery Agreement with Sanofi 24
PeptiDream Enters into Peptide Discovery Agreement with Merck 25
PeptiDream Expands Drug Discovery Agreement with Novartis 26
PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 27
PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 28
PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 29
PeptiDream Expands Drug Discovery Agreement with Amgen 30
PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 31
PeptiDream Enters into Drug Discovery Agreement with MedImmune 32
PeptiDream Extends Discovery Agreement With Bristol-Myers Squibb 33
PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 34
PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 35
Licensing Agreements 36
Eli Lilly Enters into Licensing Agreement with PeptiDream 36
Shionogi Enters into Licensing Agreement with PeptiDream 37
Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38
PeptiDream Exercises Option for Licensing Agreement with Novartis 39
PeptiDream Enters Into Licensing Agreement With Eli Lilly 40
PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 41
PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 42
Equity Offering 43
PeptiDream Raises USD53 Million in IPO 43
PeptiDream Inc – Key Competitors 44
PeptiDream Inc – Key Employees 45
PeptiDream Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 47
Corporate Communications 47
Aug 22, 2017: PeptiDream Appoints Representative Directors 47
Product News 48
12/16/2016: Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer 48
Other Significant Developments 49
Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck 49
Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Kyorin 50
May 31, 2017: PeptiDream Announces 5 th Milestone from Macrocyclic Peptide Drug Discovery Alliance with Bristol-Myers Squibb 51
Mar 22, 2017: PeptiDream Announces 1st Milestone from Macrocyclic Peptide Drug Discovery Alliance with Shionogi 52
Feb 14, 2017: PeptiDream Announces the Selection of Development Candidate from Discovery Collaboration with Daiichi Sankyo 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54
PeptiDream Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
PeptiDream Inc, Deals By Therapy Area, 2011 to YTD 2017 9
PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12
Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 13
Bayer and PeptiDream Enter into Partnership 14
PeptiDream and Kleo Pharma Enter into Co-Development Agreement 15
Heptares Therapeutics and PeptiDream Enter into Agreement 16
Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 17
PeptiDream Enters into Agreement with Janssen Pharma 18
PeptiDream Enters into Research Agreement with BIND Therapeutics 19
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 20
PeptiDream Enters into Agreement with Genentech 21
Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 22
Teijin Pharma Enters into Discovery Agreement with PeptiDream 23
PeptiDream Enters into Discovery Agreement with Sanofi 24
PeptiDream Enters into Peptide Discovery Agreement with Merck 25
PeptiDream Expands Drug Discovery Agreement with Novartis 26
PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 27
PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 28
PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 29
PeptiDream Expands Drug Discovery Agreement with Amgen 30
PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 31
PeptiDream Enters into Drug Discovery Agreement with MedImmune 32
PeptiDream Extends Discovery Agreement With Bristol-Myers Squibb 33
PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 34
PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 35
Eli Lilly Enters into Licensing Agreement with PeptiDream 36
Shionogi Enters into Licensing Agreement with PeptiDream 37
Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38
PeptiDream Exercises Option for Licensing Agreement with Novartis 39
PeptiDream Enters Into Licensing Agreement With Eli Lilly 40
PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 41
PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 42
PeptiDream Raises USD53 Million in IPO 43
PeptiDream Inc, Key Competitors 44
PeptiDream Inc, Key Employees 45
PeptiDream Inc, Other Locations 46